✦ LIBER ✦

Status of therapeutic gene transfer to treat cardiovascular disease in dogs and cats

✍ Scribed by Meg Sleeper; Lawrence T. Bish; Mark Haskins; Katherine P. Ponder; H. Lee Sweeney

Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 740 KB
Volume: 13
Category: Article
ISSN: 1760-2734
DOI: 10.1016/j.jvc.2011.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Expression of Glucokinase

Comparison of Expression of Glucokinase Gene and Activities of Enzymes Related to Glucose Metabolism in Livers between Dog and Cat

✍ A. Tanaka; A. Inoue; A. Takeguchi; T. Washizu; M. Bonkobara; T. Arai 📂 Article 📅 2005 🏛 Springer Netherlands 🌐 English ⚖ 287 KB

Use of an intravascular thrombectomy dev

Use of an intravascular thrombectomy device to treat life-threatening venous thrombosis in a patient with Crohn's disease and G20210A prothrombin gene mutation

✍ G.S. Latzman; A. Kornbluth; S.J. Murphy; P. Legnani; J. George; J. Guller; S. Le 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis. 2006;65:398 -400. 7. Braun-Moscovici Y, Markovits D, Zinder O, et al. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-a

Partial phenotypic correction and immune

Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of α-glucosidase in Pompe disease

✍ Gaëlle Douillard-Guilloux; Emmanuel Richard; Lionel Batista; Catherine Caillaud 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 1 views

## Abstract ## Background Glycogen storage disease type II (GSDII) or Pompe disease is an inherited disease of glycogen metabolism caused by a lack of functional lysosomal acid α‐glucosidase (GAA). Affected individuals store glycogen in lysosomes resulting in fatal hypertrophic cardiomyopathy and

Plasma N-terminal pro-B-type natriuretic

Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission

✍ François Serres; Jean-Louis Pouchelon; Laure Poujol; Hervé P. Lefebvre; Cathy Tr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Objectives: Although mitral valve disease (MVD) is the most common canine heart disease, readily available prognostic markers of the disease are still lacking. The aim of this study was to evaluate the comparative ability of N-terminal pro-B-type natriuretic peptide plasma concentration (NT-proBNP)